In our view, the private markets are driving innovation across modalities, and we expect both scientific and regulatory progress to persist in the next decade and beyond.
Many of biotech’s most exciting advancements are on the cusp of markedly improving the standard of care for patients in numerous diseases. In our view, the private markets are driving innovation across modalities, and we expect both scientific and regulatory progress to persist in the next decade and beyond.